November 25, 2018
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
October 14, 2018
A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...
November 2, 2017
Oncolytics Biotech announced the appointment of a new member of the board of directors.
June 14, 2017
Interest in the marijuana sector is hot. Here, INN asks experts in the industry what investors need to know before...
January 16, 2017
These three blockbuster drugs transformed pharmaceutical investing. But will we ever see anything like them again?